MEMBERS PORTAL
MEMBERS PORTAL

Category

Latest News
06
Mar

Press Release: Short Regimen for Preventing TB Found Safe When Co-administered with New First-line HIV Drug

March 6, 2019
Short Regimen for Preventing TB Found Safe When Co-administered with New First-line HIV Drug New study paves the way for scale-up of TB prevention among people living with HIV, who are dying from TB in large numbers SEATTLE (6 March 2019)—In an important moment for tuberculosis (TB) control, a new study finds that a shorter...
Read More
13
Nov

Request for proposals (RfP) for selection of new manufacturer(s) for development and commercialization of affordable Rifapentine-based formulations

November 13, 2018
Approximately, 1.7 billion individuals were latently infected with tuberculosis in 2014, just under a quarter of the global population. Among the latently infected population, people living with HIV and children under 5 who are household contacts of bacteriologically-confirmed pulmonary TB cases, are at a higher risk of progressing from latent infection to active disease. In...
Read More
26
Sep

Statement on UN High-Level Meeting on TB

September 26, 2018
When it comes to preventing TB, we can and must do better Statement by Gavin Churchyard, CEO of Aurum Institute We’ve known how to prevent and treat TB for over 70 years. Yet, in 2017 an estimated 10 million people fell ill from the disease, and every day more than 4,000 people die from TB....
Read More
27
Jul

Good news! The first IMPAACT4TB newsletter is out!

July 27, 2018
IMPAACT4TB is a four-year project introducing a new way to tackle latent TB infection — the seed bed of TB—in order to slow and ultimately stop the flood of new TB cases occurring every year.
Read More
1 2 3 4